A Systematic Overview of Chemotherapy Effects in Gastric Cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

1993 • 14,121 citations

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1990 • 900 citations

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1997 • 875 citations

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer

1997 • 843 citations

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1995 • 796 citations

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1993 • 787 citations

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

1978 • 707 citations

Progress in gastric cancer surgery in Japan and its limits of radicality

1987 • 694 citations

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.

1993 • 560 citations

Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy

1982 • 492 citations

Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

1983 • 427 citations

Effect of surgical removal on the growth and kinetics of residual tumor.

1979 • 414 citations

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

1991 • 394 citations

A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma

1985 • 393 citations

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1993 • 360 citations

5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric Cancer

1980 • 357 citations

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.

1989 • 307 citations

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

1989 • 304 citations

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

1992 • 293 citations

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)

1994 • 262 citations

Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study

1994 • 257 citations

Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination

1996 • 194 citations

Prospective Randomized Trial of Early Postoperative Intraperitoneal Chemotherapy as an Adjuvant to Resectable Gastric Cancer

1998 • 192 citations

Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy

1991 • 170 citations

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1990 • 154 citations

Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study

1994 • 153 citations

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern cooperative oncology group study (EST 3275)

1985 • 141 citations

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

1994 • 136 citations

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

1996 • 130 citations

Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion‐positive gastric cancer

1995 • 129 citations

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

1983 • 128 citations

Preoperative and Postoperative Combination Chemotherapy for Potentially Resectable Gastric Carcinoma

1993 • 126 citations

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study

1995 • 123 citations

New developments in the treatment of gastric carcinoma.

1990 • 122 citations

Preoperative chemotherapy for stage III–IV gastric carcinoma: Feasibility, response and outcome after complete resection

1995 • 119 citations

Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial

1999 • 115 citations

Neoadjuvant chemotherapy for high‐grade advanced gastric cancer

1993 • 111 citations

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group study

1976 • 110 citations

Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.

1992 • 108 citations

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

1995 • 108 citations

Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.

1994 • 108 citations

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

1994 • 106 citations

An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).

1984 • 105 citations

Adenocarcinoma of the stomach: Autopsy observations with therapeutic implications for the radiation oncologist

1986 • 104 citations

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

1991 • 101 citations

Sequential and combination chemotherapy of advanced gastric cancer

1976 • 101 citations

Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial

1991 • 96 citations

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracil

1991 • 91 citations

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.

1992 • 86 citations

Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer.

1984 • 83 citations

Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer

1996 • 83 citations

New developments in the treatment of gastric carcinoma

1991 • 82 citations

Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion.

1995 • 80 citations

Prophylaxis and treatment of peritoneal carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles

1995 • 80 citations

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival

1996 • 79 citations

Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach

1969 • 74 citations

Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.

1986 • 72 citations

Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

1994 • 72 citations

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk

1990 • 71 citations

Relaitonship between area of serosal invasion and prognosis in patient with gastric carcinoma

1987 • 69 citations

Mitomycin C as an Adjuvant Treatment to Resected Gastric Cancer

1991 • 68 citations

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

1993 • 64 citations

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group

1983 • 57 citations

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer

1996 • 56 citations

Chemotherapy of carcinoma of the stomach

1993 • 55 citations

Neoadjuvant chemotherapy for gastric cancer: Update

1995 • 54 citations

Review of adjuvant chemotherapy for gastric cancer

1995 • 54 citations

Potentially resectable gastric carcinoma: Current approaches to staging and preoperative therapy

1995 • 53 citations

Mitomycin C as an Adjuvant in Resected Gastric Cancer

1983 • 51 citations

Epirubucin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An italian group for the study of digestive tract cancer (GISCAD) report

1995 • 50 citations

Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C.

1978 • 49 citations

Gastric Cancer: Preoperative chemotherapy of locally advanced gastric cancer

1994 • 49 citations

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

1993 • 45 citations

Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.

1989 • 45 citations

A Randomized Trial Comparing Adjuvant Fluorouracil, Epirubicin, and Mitomycin with No Treatment in Operable Gastric Cancer

1996 • 44 citations

A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer

1991 • 42 citations

Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma

1994 • 41 citations

Adjuvant chemotherapy in gastric cancer

1987 • 39 citations

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients

1992 • 39 citations

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

1998 • 37 citations

Gastric carcinoma treated by chemotherapy after resection

1980 • 34 citations

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen

1998 • 33 citations

Adjuvant Chemotherapy with Mitomycin C, and with a Multi-drug Combination of Mitomycin C, 5-Fluorouracil and Cytosine Arabinoside after Curative Resection of Gastric Cancer

1980 • 33 citations

The Effect of Adjuvant Chemotherapy in Gastric Carcinoma Is Dependent on Tumor Histology: 5- Year Results of a Prospective Randomized Trial

1988 • 29 citations

Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer

1994 • 29 citations

Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomized trial.

1989 • 29 citations

Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study

1995 • 29 citations

Current strategies in the management of locoregional and metastatic gastric carcinoma

1991 • 28 citations

Adjuvant 5-Fluorouracil and BCNU Chemotherapy in Gastric Cancer: 3-Year Results

1982 • 28 citations

Adjuvant therapy of gastric cancer: the Japanese experience.

1996 • 23 citations

5-Fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma

1994 • 22 citations

Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive Chemotherapy

1995 • 22 citations

Preoperative chemotherapy for unresectable gastric cancer

1995 • 21 citations

A pilot study of intraperitoneal cisplatin in the management of gastric cancer

1994 • 20 citations

Adjuvant treatment of gastric cancer

1995 • 18 citations

Gastric Cancer: Current status and future directions in the treatment of localized gastric cancer

1994 • 18 citations

Adjuvant therapy in resectable gastric cancer

1992 • 17 citations

5-Fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer

1984 • 14 citations

Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.

1995 • 13 citations

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma

1990 • 12 citations

Etoposide (E) + epirebicin (E) + cisplatin (P) combination chemotherapy (EEP) In advanced gastric cancer: Negative impact on clinical outcome

1992 • 12 citations

A phase I–II study of epirubicin, 5-fluorouracil, and leucovorin in advanced adenocarcinoma of the stomach

1993 • 10 citations

Neo-adjuvant chemotherapy with carboplatin, 4-epiadriamycin and teniposide (CET) in locally advanced cancer of the cardia and the lower oesophagus: a phase II study.

1995 • 10 citations

Preoperative intraperitoneal chemotherapy for gastric cancer, with special reference to delayed peritoneal complications

1995 • 9 citations

5-Fluorouracil, Epirubicin, and Mitomycin C Versus 5-Fluorouracil, Epirubicin, Mitomycin C, and Leucovorin in Advanced Gastric Carcinoma

1996 • 9 citations

Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvement

1994 • 7 citations

Adjuvant treatment for gastric cancer

1991 • 7 citations

MMAF for advanced gastric cancer

1991 • 7 citations

Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles for patients with advanced gastric cancer.

1994 • 7 citations

Combination Chemotherapy with Tegafur-Uracil (UFT), Etoposide, Adriamycin and Cisplatinum (UFT-EAP) for Advanced Gastric Cancer

1994 • 6 citations

Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ cooperative group

1995 • 6 citations

[Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].

1994 • 6 citations

Evaluation of Two Consecutive Regimens in Advanced Gastric Cancer

1991 • 6 citations

Carboplatin and Etoposide in Patients with Advanced Gastric Cancer

1993 • 6 citations

Perspectives in chemotherapy of advanced gastric cancer

1991 • 5 citations

Phase II Trial of Etoposide, Doxorubicin, and Cisplatin Combination in Advanced Measurable Gastric Cancer

1995 • 5 citations

Chemotherapy of advanced gastrointestinal cancer

1994 • 5 citations

Intraperitoneal administration of cisplatin and etoposide during surgery for patients with gastric cancer.

1993 • 5 citations

Continuous Infusion 5-Fluorouracil with Bolus Adriamycin and Mitomycin and Low-Dose Cisplatin (FAMP) in the Treatment of Metastatic Gastric Carcinoma: An Evaluation of Efficacy and Toxicity

1991 • 4 citations

Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule

1994 • 4 citations

Mitomycin-c, Adriamycin, 5-Fluorouracil and Leucovorin (L-FAM₂) in the Treatment of Advanced Gastric Cancer: A Phase II Study

1991 • 3 citations

Alternating chemotherapy in advanced gastric cancer

1991 • 1 citations

Etoposide, Doxorubicin and Cisplatin (EAP Regimen) in Advanced Gastric Cancer

1994 • 1 citations